Northern Trust Corp Vaccinex, Inc. Transaction History

Northern Trust Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $2,985 - $679,239	6,219 Added 36.26%	23,369 $12,000
Q2 2022 Aug 12, 2022	BUY	$1.05 - $1.39 $470 - $622	448 Added 2.68%	17,150 $19,000
Q1 2021 May 12, 2021	BUY	$2.09 - $5.11 $418 - $1,022	200 Added 1.21%	16,702 $50,000
Q4 2020 Feb 11, 2021	BUY	$1.66 - $2.35 $4,382 - $6,204	2,640 Added 19.04%	16,502 $34,000
Q3 2020 Nov 16, 2020	BUY	$1.75 - $8.19 $5,484 - $25,667	3,134 Added 29.21%	13,862 $25,000
Q2 2020 Aug 14, 2020	SELL	$3.28 - $4.24 $1,872 - $2,421	-571 Reduced 5.05%	10,728 $39,000
Q4 2018 Feb 12, 2019	SELL	$3.64 - $7.12 $5,401 - $10,566	-1,484 Reduced 11.61%	11,299 $41,000
Q3 2018 Nov 14, 2018	BUY	$6.95 - $11.64 $88,841 - $148,794	12,783 New	12,783 $93,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $240M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.